alnylam.com

Alnylam Pharmaceuticals


Alnylam (Nasdaq: ALNY) is the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare genetic, cardio-metabolic, hepatic infectious, and central nervous system (CNS)/ocular diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach for the treatment of a wide range of severe and debilitating diseases.
View Top Employees for Alnylam Pharmaceuticals
img Website alnylam.com
img Industry Biotechnology
img Location Cambridge, Massachusetts, United States
img Employees 1,542
img Founded 2002
img Website alnylam.com
img Industry Biotechnology
img Location Cambridge, Massachusetts, United States
img Employees 1,542
img Founded 2002
img LinkedIn linkedin.com/company/alnylam-pharmaceuticals

Top Alnylam Pharmaceuticals Employees